Anesiva insitate Phase II trual of Adlea in Arthroscopic Shoulder Surgery

Anesiva have begun a Phase II clinical trial of Adlea, the company’s long-acting capsaicin product in for the management of acute pain in patients undergoing arthroscopic shoulder surgery involving rotator cuff repair.

Anesiva Needle-Free Zingo for reducing pain from IV Starts and Blood Draws in Children

Anesiva has launched its Zingo (lidocaine hydrochloride monohydrate) powder intradermal injection system for use in  reducing the pain associated with peripheral intravenous line placements and blood draws in children three to 18 years of age.

Phase II trials of Adlea in post orthopedic surgery pain to take place in South Korea

Anesiva to begin Phase II trial of Capsaicin drug Adlea for use in the treatment of post orthopedic surgery pain.

FDA accepts Zingo (lidocaine) sNDA for needle associated pain

The FDA has accepted Anesiva’s sNDA for Zingo (lidocaine intradermal injection) for the treatment of pain associated with peripheral IV insertions and blood draws in adults. Zingo was approved in 2007 for local analgesia prior to peripheral IV insertions and blood draws in children.